Health Canada is conducting a safety review of domperidone, a drug often prescribed off-label to breastfeeding mothers as a way to boost milk supply, after reports have alleged withdrawal symptoms and psychiatric concerns after stopping the medication.
A spokesperson for Health Canada told the Epoch Times in an emailed statement that it is “proactively” monitoring the safety of domperidone maleate.
